Page last updated: 2024-08-21

isoxazoles and sulfasalazine

isoxazoles has been researched along with sulfasalazine in 106 studies

Research

Studies (106)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (3.77)	18.2507
2000's	60 (56.60)	29.6817
2010's	42 (39.62)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kalden, JR; Kvien, TK; Larsen, A; Loew-Friedrich, I; Oed, C; Rosenburg, R; Rozman, B; Scott, DL; Smolen, JS	1
Cherin, P	1
Emery, P	1
Scott, DL	2
Hurley, F; Leung, H; Loew-Friedrich, I; Sharp, JT; Strand, V	1
Kremer, JM	1
O'Dell, J	1
Kvien, TK; Larsen, A; Oed, C; Rau, R; Rosenburg, R; Rozman, B; Schattenkirchner, M; Scott, DL; Smolen, JS; Tikly, M; Westhovens, R	1
Wasko, MC; Wildy, KS	1
Jones, P; Kalden, JR; Kvien, TK; Oed, C; Rosenburg, R; Rozman, B; Schattenkirchner, M; Scott, DL; Smolen, JS; Williams, BD; Williams, RB	1
Kalden, JR; Kvien, TK; Larsen, A; Loew-Friedrich, I; Nash, P; Oed, C; Schattenkirchner, M; Scott, DL; Smolen, JS; van de Putte, LB	1
Pisetsky, DS; St Clair, EW	1
Ilowite, NT	1
Doyle, J; Huse, DM; Ollendorf, DA; Peterson, AN	1
Choi, HK; Kuntz, KM; Seeger, JD	1
Scott, DL; Strand, V	1
Krüger, K	2
Kellner, H; Schiemann, U	1
Hirohata, S	1
Osiri, M; Robinson, V; Shea, B; Strand, V; Suarez-Almazor, M; Tugwell, P; Wells, G	1
Gross, WL; Schnabel, A	1
Balabanova, RM	1
Aletaha, D; Eberl, G; Grisar, J; Kapral, T; Machold, KP; Smolen, JS; Stamm, T	1
Breedveld, FC; Dougados, M; Emery, P; Kalden, JR; Smolen, JS; Strand, CV; van Riel, PL	1
Burmester, GR; Müller-Ladner, U; Rüther, W	1
Brin, S; Dougados, M; Emery, P; Lemmel, EM; van Riel, P; Zerbini, CA	1
Emery, P; Suarez-Almazor, M	1
Gladman, DD	1
Issa, SN; Ruderman, EM	1
Chandler, D; Griffiths, CE; Helliwell, P; Kyle, S; Lewis, J; McHugh, N; McInnes, I; Oliver, S; Symmons, D	1
Bolten, W; Krüger, K	1
Kawabata, D; Mimori, T	1
Sugii, S	1
Cannon, GW; Crawford, B; Emery, P; Kalden, JR; Scott, DL; Smolen, JS; Strand, V; Tugwell, P	1
Fath, R	1
Burmester, GR	1
Derk, CT	1
Furst, DE; Ranganath, VK	2
Resman-Targoff, BH	1
Braun, J; Sieper, J	1
Berthelot, JM; Cantagrel, A; Combe, B; de Bandt, M; Fautrel, B; Flipo, RM; Guillemin, F; Le Loët, X; Lioté, F; Maillefert, JF; Meyer, O; Saraux, A; Wendling, D	1
Allaart, CF; Breedveld, FC; de Vries-Bouwstra, JK; Dijkmans, BA; Gerards, AH; Goekoop-Ruiterman, YP; Hazes, JM; Kerstens, PJ; van der Kooij, SM; van Groenendael, JH; van Zeben, D	1
Aletaha, D; Kapral, T; Schoels, M; Smolen, JS; Stamm, T	1
Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T	1
Tłustochowicz, W	1
Matsuda, T; Ohtsubo, H	1
Choy, EH; Ravindran, V; Scott, DL	1
McHugh, NJ; Soriano, ER	1
Chambers, C; Johnson, D; Jones, KL; Koren, G; Tutuncu, ZN	1
Bingham, CO; Miner, MM	1
Borm, GF; Fransen, J; Lemmens, WA	1
Li, SG	1
Sizova, L	1
Homer, D; Jobanputra, P; Nightingale, P	1
Yamanaka, H	1
Brasington, R	1
Gergely, P; Poór, G	1
Mimori, T; Yukawa, N	1
Förger, F; Østensen, M	1
Goh, L; Samanta, A	1
Díaz, J; González, A; Mora, C; Quintana, G	1
Chang, YJ; Chen, LA; Hsu, YL; Su, LH; Tsai, TH	1
Bambery, P; Jose, V; Mittal, N; Mittal, R; Sharma, A; Wanchu, A	1
Matuszewska, A; Misterska-Skóra, M; Wiland, P	1
Boulinguez, S; Goupille, P; Passeron, T	1
Kiss, CG; Kiss, E; Poór, G	1
Arbogast, PG; Chen, L; Curtis, JR; Delzell, E; Griffin, MR; Grijalva, CG; Herrinton, L; Kawai, VK; Liu, L; Mitchel, EF; Ouellet-Hellstrom, R; Solomon, DH; Stein, CM	1
Ichikawa, N; Yamanaka, H	1
Golicki, D; Hermanowski, T; Lis, J; Newada, M; Pol, K; Tłustochowicz, M	1
Choi, SW; Kim, YG; Lee, CK; Lee, SG; Oh, JS; So, MW; Yoo, B	1
An, Y; Chen, HY; Chen, LN; Cui, LF; Duan, TJ; Gao, M; Han, SL; Hu, SX; Huang, CB; Jia, B; Jin, HT; Ke, D; Lai, P; Li, GT; Li, H; Li, JF; Li, XF; Li, ZB; Li, ZG; Lin, JY; Liu, BL; Liu, T; Liu, XM; Liu, XY; Lu, X; Mu, R; Shu, R; Song, LJ; Su, Y; Sun, L; Tao, JM; Wang, CH; Wang, GC; Wang, LZ; Wang, XR; Wang, XY; Wang, Y; Wang, YF; Wei, MQ; Yang, J; Yang, R; Yang, XY; Ye, C; Zhang, FX; Zhang, XY; Zhang, ZL; Zhou, YS; Zhu, JX; Zhu, P	1
Lubrano, E; Scarpa, R	1
Miller, AV; Ranatunga, SK	1
Davis, JM; Matteson, EL	1
Brun, JG; Kajalainen, A; Kautiainen, H; Knight, A; Ljung, L; Luukkainen, R; Nordström, D; Pettersson, T; Proven, A; Rantalaiho, V; van Vollenhoven, R	1
Combe, B; Cristol, JP; Daïen, CI; Daïen, V; du Cailar, G; Dupuy, AM; Fesler, P; Morel, J; Mura, T; Ribstein, J	1
Gučev, F; Hočevar, A; Marolt, VF; Perdan-Pirkmajer, K; Rotar, Ž; Tomšič, M; Žibert, J	1
Ballesteros, F; Cardiel, MH; Cordeiro de Azevedo, AB; da Silveira, IG; Esquivel-Valerio, JA; García-De La Torre, I; Hernandez, MP; Khoury, VJ; Marcos, JC; Massardo, L; Millán, A; Oñate, RV; Pinto, MR; Pons-Estel, BA; Radominski, SC; Rojas-Villarraga, A; Sacnun, MP; Saurit, V; Soriano, ER; Wojdyla, D; Ximenes, AC	1
Cleland, LG; Flabouris, K; James, MJ; Lee, AT; Metcalf, RG; Proudman, SM; Rischmueller, M; Spargo, LD; Sullivan, TR; Wechalekar, MD	1
Cron, RQ; Stoll, ML	1
Chen, DY; Chen, HH; Chen, YM; Chou, P; Chou, YJ; Huang, N; Lai, KL; Lin, CH	1
Biswas, M; Chatterjee, S; Ghosh, A; Ghosh, S; Sarkate, P	1
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D	1
Castro, C; de la Hoz-Valle, J; Palomino, A; Sánchez, G; Santos-Moreno, PI; Villarreal, L	1
Corluy, L; De Brabanter, G; De Cock, D; Durnez, A; Geens, E; Geusens, P; Joly, J; Joos, R; Langenaken, C; Lenaerts, J; Meyfroidt, S; Raeman, F; Ravelingien, I; Remans, J; Sileghem, A; Taelman, V; Van der Elst, K; Van Essche, E; Vander Cruyssen, B; Vandevyvere, K; Vanhoof, J; Verschueren, P; Westhovens, R	2
Dejaco, C; Duftner, C; Ficjan, A; Graninger, WB; Gretler, J; Gutierrez, M; Hermann, J; Husic, R; Lackner, A	1
Onuora, S	1
Harman, H; Harman, S; Kaban, N; Tekeoğlu, I	1
Foley, P; Kelly, JB; Strober, BE	1
Fautrel, B; Gaujoux-Viala, C; Tsonaka, R; van der Helm-van Mil, AH; van Nies, JA	1
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L	1
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM	1
Cummins, L; Duggan, E; Katikireddi, VS; Pahau, H; Shankaranarayana, S; Su, KY; Thomas, R; Videm, V	1
Brandão, MAF; Ferreira, AO; Patrício, FB; Polonini, HC; Raposo, NRB; Silva, SL	1
Horneff, G; Hügle, B	1
Barner, JC; Kim, G; Rascati, K; Richards, K	1
Gerosa, M; Meroni, PL; Schioppo, T	1
Chen, DY; Chen, YM; Liao, TL; Liu, HJ	1
Adwan, MH	1
Acevedo-Vásquez, EM; Alarcón-Riquelme, ME; Alvarellos, A; Babini, A; Ballesteros, F; Berbotto, G; Cardiel, MH; Catoggio, LJ; Citera, G; Eimon, A; Esquivel-Valerio, JA; García de la Torre, I; García, CG; Goñi, M; Graf, C; Maradiaga-Ceceña, MA; Marcos, JC; Messina, OD; Miranda, P; Moreno, JLC; Musuruana, JL; Nasswetter, G; Paira, S; Pellet, AC; Pons-Estel, BA; Quinteros, A; Sacnún, M; Sánchez, E; Scherbarth, H; Spindler, A; Strusberg, I; Tate, G; Toloza, S; Tusié-Luna, T	1
Fleury, G; Gabay, C; Hannouche, D; Mania, S	1

Reviews

49 review(s) available for isoxazoles and sulfasalazine

Article	Year
[62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998]. La Revue de medecine interne, 1999, Volume: 20, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Child, Preschool; Etanercept; Female; Humans; Immunoglobulin G; Immunoglobulin gamma-Chains; Immunoglobulin Heavy Chains; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Recombinant Proteins; Rheumatology; Societies, Medical; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha	1999
Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Annals of internal medicine, 2001, Apr-17, Volume: 134, Issue:8 Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine	2001
Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis. Hand clinics, 2001, Volume: 17, Issue:2 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Digestive System; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Lactones; Leflunomide; Methotrexate; Osteoarthritis; Pyrazoles; Receptors, Tumor Necrosis Factor; Sulfasalazine; Sulfonamides; Sulfones	2001
Progress in the treatment of rheumatoid arthritis. JAMA, 2001, Dec-12, Volume: 286, Issue:22 Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine	2001
Current treatment of juvenile rheumatoid arthritis. Pediatrics, 2002, Volume: 109, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Child; Contraindications; Etanercept; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine	2002
Advances in the medical management of rheumatoid arthritis. Hospital medicine (London, England : 1998), 2002, Volume: 63, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Steroids; Sulfasalazine; Treatment Outcome	2002
[Gastrointestinal side effects in the therapy of rheumatologic diseases]. Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:11 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Etanercept; Gastrointestinal Diseases; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Stomach Ulcer; Sulfasalazine; Tumor Necrosis Factor-alpha	2002
[Efficacy of leflunomide]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:12 Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase II as Topic; Double-Blind Method; Humans; Isoxazoles; Leflunomide; Liver Diseases; Methotrexate; Mice; Sulfasalazine	2002
Leflunomide for treating rheumatoid arthritis. The Cochrane database of systematic reviews, 2003, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine	2003
[Current concepts of pharmacotherapy in rheumatoid arthritis]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:7 Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Cyclophosphamide; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Ibuprofen; Immunosuppressive Agents; Isoxazoles; Ketoprofen; Leflunomide; Male; Methotrexate; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfasalazine; Time Factors	2003
Lefunomide in combination therapy. The Journal of rheumatology. Supplement, 2004, Volume: 71 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infliximab; Isoxazoles; Leflunomide; Male; Randomized Controlled Trials as Topic; Risk Factors; Sulfasalazine; Treatment Outcome	2004
[Diagnosis and therapy of rheumatoid arthritis]. Deutsche medizinische Wochenschrift (1946), 2004, Jun-04, Volume: 129, Issue:23 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty; Cyclooxygenase Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatoid Factor; Sulfasalazine	2004
Rheumatoid arthritis. Clinical evidence, 2003, Issue:9 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine	2003
Psoriatic arthritis. Dermatologic therapy, 2004, Volume: 17, Issue:5 Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors	2004
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction. Postgraduate medicine, 2004, Volume: 116, Issue:5 Topics: Arthritis, Rheumatoid; Azathioprine; Disease Progression; Humans; Hydroxychloroquine; Immunologic Factors; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine	2004
Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology (Oxford, England), 2005, Volume: 44, Issue:3 Topics: Algorithms; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2005
[Disease modifying anti-rheumatic drugs (DMARDs): an overview]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Benzopyrans; Cysteine; Evidence-Based Medicine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Sulfonamides	2005
[Adverse effects of DMARDs in treatment of rheumatoid arthritis]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; Humans; Isoxazoles; Kidney Diseases; Leflunomide; Lung Diseases, Interstitial; Male; Methotrexate; Reproduction; Sulfasalazine	2005
Rheumatoid arthritis: an update. Delaware medical journal, 2005, Volume: 77, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine	2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Clinics in geriatric medicine, 2005, Volume: 21, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cytokines; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Treatment Outcome	2005
Medical therapy: where are we now? American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Sep-15, Volume: 63, Issue:18 Suppl 4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Treatment Outcome	2006
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Rheumatic diseases clinics of North America, 2007, Volume: 33, Issue:1 Topics: Aged; Aging; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Glomerular Filtration Rate; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine	2007
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)]. Clinical calcium, 2007, Volume: 17, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Disease Progression; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Radiography; Remission Induction; Sulfasalazine	2007
[Rational therapeutic approach in rheumatoid arthritis]. Annales Academiae Medicae Stetinensis, 2006, Volume: 52 Suppl 2 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isoxazoles; Joint Prosthesis; Leflunomide; Methotrexate; Prostheses and Implants; Sulfasalazine	2006
[Effective combination therapy of TNF antagonists with DMARDs]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:7 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha	2007
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis. Annals of the rheumatic diseases, 2008, Volume: 67, Issue:6 Topics: Alefacept; Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Humans; Isoxazoles; Leflunomide; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Risk Assessment; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
Conventional therapy of psoriatic arthritis: evidence-based review. Reumatismo, 2007, Volume: 59 Suppl 1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome	2007
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study. Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:3 Topics: Abnormalities, Drug-Induced; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Incidence; Information Services; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Risk Assessment; Sulfasalazine; Teratogens	2007
Treatment, management, and monitoring of established rheumatoid arthritis. The Journal of family practice, 2007, Volume: 56, Issue:10 Suppl R Topics: Abatacept; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Drug Therapy, Combination; Etanercept; Humans; Hydrotherapy; Hydroxychloroquine; Immunoconjugates; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Physical Therapy Modalities; Primary Health Care; Prognosis; Quality of Life; Receptors, Tumor Necrosis Factor; Rituximab; Severity of Illness Index; Sulfasalazine; Treatment Outcome	2007
Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs. British journal of clinical pharmacology, 2008, Volume: 66, Issue:2 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Humans; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Quality of Life; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
[Antirheumatic agents for treatment of rheumatoid arthritis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Oct-10, Volume: 97, Issue:10 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Pharmacogenetics; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine; Time Factors	2008
[New ways in the management of rheumatoid arthritis in Hungary]. Lege artis medicinae : uj magyar orvosi hirmondo, 2007, Volume: 17, Issue:10 Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha	2007
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis]. Clinical calcium, 2009, Volume: 19, Issue:3 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus	2009
Management of RA medications in pregnant patients. Nature reviews. Rheumatology, 2009, Volume: 5, Issue:7 Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult	2009
A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis. Rheumatology international, 2009, Volume: 29, Issue:10 Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diphosphonates; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Pamidronate; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Steroids; Sulfasalazine; Tumor Necrosis Factor-alpha	2009
New-onset psoriasis associated with etanercept therapy. The Journal of dermatology, 2010, Volume: 37, Issue:4 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Prednisolone; Psoriasis; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha	2010
[Systemic autoimmune disorders and pregnancy]. Orvosi hetilap, 2011, Oct-23, Volume: 152, Issue:43 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha	2011
[ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs]. Clinical calcium, 2012, Volume: 22, Issue:2 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Clinical Trials as Topic; Cysteine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Sulfasalazine; Tacrolimus	2012
Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials. Polskie Archiwum Medycyny Wewnetrznej, 2012, Volume: 122, Issue:1-2 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Outcome	2012
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs. Reumatismo, 2012, Jun-05, Volume: 64, Issue:2 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine	2012
Immunotherapies in rheumatologic disorders. The Medical clinics of North America, 2012, Volume: 96, Issue:3 Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors	2012
My treatment approach to rheumatoid arthritis. Mayo Clinic proceedings, 2012, Volume: 87, Issue:7 Topics: Abatacept; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Comorbidity; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunoconjugates; Isoxazoles; Joints; Leflunomide; Methotrexate; Prednisone; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Referral and Consultation; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2012
Treatment of juvenile idiopathic arthritis in the biologic age. Rheumatic diseases clinics of North America, 2013, Volume: 39, Issue:4 Topics: Abatacept; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Juvenile; Child; Etanercept; Humans; Immunoconjugates; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha	2013
Current and future oral systemic therapies for psoriasis. Dermatologic clinics, 2015, Volume: 33, Issue:1 Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine	2015
The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:5 Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Drug Therapy, Combination; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Quality of Life; Sulfasalazine	2016
Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:11 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine; Treatment Outcome	2016
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist. Current rheumatology reports, 2017, Volume: 19, Issue:1 Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Bone Density Conservation Agents; Drug Hypersensitivity Syndrome; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Sulfasalazine	2017
[Perioperative management of immunosuppressive treatment in patients undergoing joint surgery]. Zeitschrift fur Rheumatologie, 2017, Volume: 76, Issue:9 Topics: Adrenal Cortex Hormones; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement; Biological Products; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Perioperative Care; Risk Factors; Sulfasalazine; Surgical Wound Infection; Wound Healing	2017
The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Swiss medical weekly, 2017, Volume: 147 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Products; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Methotrexate; Perioperative Care; Risk Factors; Sulfasalazine; Surgical Procedures, Operative	2017

Trials

16 trial(s) available for isoxazoles and sulfasalazine

Article	Year
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet (London, England), 1999, Jan-23, Volume: 353, Issue:9149 Topics: Algorithms; Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Placebos; Radiography; Statistics, Nonparametric; Sulfasalazine; Treatment Outcome	1999
Disease modification in rheumatoid arthritis with leflunomide. Scandinavian journal of rheumatology. Supplement, 1999, Volume: 112 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Radiography; Sulfasalazine; Time Factors	1999
Leflunomide improves quality of life in rheumatoid arthritis. Scandinavian journal of rheumatology. Supplement, 1999, Volume: 112 Topics: Activities of Daily Living; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Quality of Life; Sulfasalazine	1999
Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and rheumatism, 2000, Volume: 43, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Humans; Isoxazoles; Leflunomide; Methotrexate; Placebos; Radiography; Sulfasalazine	2000
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scandinavian journal of rheumatology, 2001, Volume: 30, Issue:3 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Disease Progression; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Radiography; Sulfasalazine; Treatment Outcome	2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. The Journal of rheumatology, 2001, Volume: 28, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cohort Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Isoxazoles; Leflunomide; Long-Term Care; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Probability; Prognosis; Range of Motion, Articular; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome	2001
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Annals of the rheumatic diseases, 2001, Volume: 60, Issue:10 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Confidence Intervals; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Logistic Models; Male; Middle Aged; Radiography; Rheumatoid Factor; Statistics, Nonparametric; Sulfasalazine; Treatment Outcome	2001
The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database. Rheumatology (Oxford, England), 2002, Volume: 41, Issue:8 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Female; Follow-Up Studies; Health Status; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Placebos; Sulfasalazine; Surveys and Questionnaires; Time Factors	2002
When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Annals of the rheumatic diseases, 2005, Volume: 64, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Sulfasalazine; Treatment Failure; Treatment Outcome	2005
Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the rheumatic diseases, 2007, Volume: 66, Issue:10 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Kaplan-Meier Estimate; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Sulfasalazine; Treatment Failure; Treatment Outcome	2007
Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal care, 2009, Volume: 7, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Counseling; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Patient Satisfaction; Pilot Projects; Sulfasalazine; Young Adult	2009
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study. The Journal of rheumatology, 2012, Volume: 39, Issue:10 Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Interleukin-1; Remission Induction; Still's Disease, Adult-Onset; Sulfasalazine; Treatment Outcome	2012
Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Annals of the rheumatic diseases, 2013, Volume: 72, Issue:6 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Echocardiography; Etanercept; Female; Humans; Hypertrophy, Left Ventricular; Immunoglobulin G; Isoxazoles; Leflunomide; Methotrexate; Middle Aged; Pulse Wave Analysis; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Stiffness	2013
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the rheumatic diseases, 2015, Volume: 74, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Early Medical Intervention; Eicosapentaenoic Acid; Female; Fish Oils; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Remission Induction; Sulfasalazine; Treatment Outcome	2015
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Annals of the rheumatic diseases, 2015, Volume: 74, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Early Medical Intervention; Female; Glucocorticoids; Humans; Induction Chemotherapy; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Risk Assessment; Severity of Illness Index; Sulfasalazine; Treatment Outcome	2015
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-la Annals of the rheumatic diseases, 2017, Volume: 76, Issue:3 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Risk Factors; Severity of Illness Index; Sulfasalazine	2017

Other Studies

41 other study(ies) available for isoxazoles and sulfasalazine

Article	Year
Conventional DMARD options for patients with a suboptimal response to methotrexate. The Journal of rheumatology. Supplement, 2001, Volume: 62 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine	2001
[Chronic polyarthritis]. MMW Fortschritte der Medizin, 2001, May-24, Volume: 143, Issue:21 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Humans; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Outcome	2001
Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population. The American journal of managed care, 2002, Volume: 8, Issue:7 Suppl Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cost of Illness; Drug Costs; Etanercept; Female; Health Care Costs; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Managed Care Programs; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine; United States	2002
A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis. The Journal of rheumatology, 2002, Volume: 29, Issue:6 Topics: Analysis of Variance; Arthritis, Rheumatoid; Cohort Studies; Cost-Benefit Analysis; Decision Making; Etanercept; Female; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Pain Measurement; Probability; Prospective Studies; Receptors, Tumor Necrosis Factor; Sensitivity and Specificity; Sulfasalazine; Treatment Outcome; United States	2002
[2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine]. Zeitschrift fur Rheumatologie, 2002, Volume: 61, Issue:3 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine	2002
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents]. Deutsche medizinische Wochenschrift (1946), 2003, Jan-24, Volume: 128, Issue:4 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors	2003
Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study. Annals of the rheumatic diseases, 2003, Volume: 62, Issue:10 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chi-Square Distribution; Databases, Factual; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Statistics, Nonparametric; Sulfasalazine; Time Factors; Treatment Failure	2003
[Treatment with leflunomide in rheumatoid arthritis]. Zeitschrift fur Rheumatologie, 2005, Volume: 64, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Europe; Humans; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Treatment Outcome	2005
Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. The Journal of rheumatology, 2005, Volume: 32, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Disability Evaluation; Double-Blind Method; Female; Health Status; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Sulfasalazine; Surveys and Questionnaires	2005
[When to begin rheumatism treatment? Initial combination therapy helps fastest]. MMW Fortschritte der Medizin, 2004, Sep-09, Volume: 146, Issue:37 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2004
[Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?]. MMW Fortschritte der Medizin, 2004, Sep-09, Volume: 146, Issue:37 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2004
[Spondylarthritides]. Zeitschrift fur Rheumatologie, 2006, Volume: 65, Issue:7 Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine	2006
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy. Joint bone spine, 2007, Volume: 74, Issue:1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Decision Support Techniques; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Methotrexate; Practice Guidelines as Topic; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Sulfasalazine; Treatment Failure	2007
Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study. Annals of the rheumatic diseases, 2007, Volume: 66, Issue:8 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Sulfasalazine; Treatment Failure	2007
A simple sample size formula for analysis of covariance in randomized clinical trials. Journal of clinical epidemiology, 2007, Volume: 60, Issue:12 Topics: Analysis of Variance; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Randomized Controlled Trials as Topic; Research Design; Sample Size; Sulfasalazine; Treatment Outcome	2007
Clinical images: healing of sacroiliitis with leflunomide and sulfasalazine treatment. Arthritis and rheumatism, 2008, Volume: 58, Issue:5 Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Humans; Isoxazoles; Leflunomide; Male; Sacroiliac Joint; Sulfasalazine; Tomography, X-Ray Computed	2008
Disease-modifying antirheumatic drugs. The Journal of hand surgery, 2009, Volume: 34, Issue:2 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine	2009
[Financial cost of early rheumatoid arthritis in the first year of medical attention: three clinical scenarios in a third-tier university hospital in Colombia]. Biomedica : revista del Instituto Nacional de Salud, 2009, Volume: 29, Issue:1 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Protocols; Colombia; Diagnostic Services; Direct Service Costs; Disease Management; Drug Costs; Drug Therapy, Combination; Etanercept; Health Care Costs; Hospital Costs; Hospitals, University; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Meloxicam; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Thiazines; Thiazoles	2009
Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients. Rheumatology international, 2012, Volume: 32, Issue:3 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; India; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Time Factors	2012
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy]. Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine	2010
[Recommendations on the management of psoriatic arthritis]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:6 Suppl 1 Topics: Analgesics; Antirheumatic Agents; Arthritis, Psoriatic; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intra-Articular; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Tumor Necrosis Factor-alpha	2011
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Arthritis care & research, 2011, Volume: 63, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Narcotics; Retrospective Studies; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4⁺CD25⁺ regulatory T cells. Rheumatology international, 2013, Volume: 33, Issue:2 Topics: Antibodies, Monoclonal; Antigen-Presenting Cells; Antirheumatic Agents; Forkhead Transcription Factors; Humans; Infliximab; Isoxazoles; Leflunomide; Lymphocyte Activation; Methotrexate; RNA, Messenger; Sulfasalazine; T-Lymphocytes, Regulatory	2013
[Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2012, Apr-18, Volume: 44, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; China; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Sulfasalazine; Surveys and Questionnaires	2012
Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry. Rheumatology international, 2013, Volume: 33, Issue:11 Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Registries; Slovenia; Sulfasalazine; Tumor Necrosis Factor-alpha	2013
Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:7 Topics: Adult; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Disease Management; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoxazoles; Latin America; Leflunomide; Male; Methotrexate; Middle Aged; Registries; Sulfasalazine; Treatment Outcome	2012
Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:8 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Periodontitis; Receptors, Tumor Necrosis Factor; Retrospective Studies; Risk Assessment; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha	2013
Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs. The Journal of the Association of Physicians of India, 2013, Volume: 61, Issue:8 Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Methylprednisolone; Middle Aged; Severity of Illness Index; Sulfasalazine; Triglycerides; Young Adult	2013
Psoriatic arthritis treatment and the risk of herpes zoster. Annals of the rheumatic diseases, 2016, Volume: 75, Issue:1 Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha	2016
Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study. Clinical rheumatology, 2015, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Retrospective Studies; Sulfasalazine; Treatment Outcome; Young Adult	2015
Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score). Arthritis research & therapy, 2014, Oct-31, Volume: 16, Issue:5 Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Bone and Bones; Feasibility Studies; Female; Follow-Up Studies; Humans; Inflammation; Isoxazoles; Joints; Leflunomide; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Sulfasalazine; Surveys and Questionnaires; Synovial Membrane; Tendons; Time Factors; Ultrasonography, Doppler	2014
Rheumatoid arthritis: Methotrexate and bridging glucocorticoids in early RA. Nature reviews. Rheumatology, 2014, Volume: 10, Issue:12 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Isoxazoles; Male; Methotrexate; Prednisone; Sulfasalazine	2014
Factors influencing ultrasonographic remission in patients with rheumatoid arthritis. Rheumatology international, 2015, Volume: 35, Issue:3 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Delayed Diagnosis; Etanercept; Female; Hand Joints; Humans; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Remission Induction; Rituximab; Severity of Illness Index; Sulfasalazine; Synovitis; Tenosynovitis; Time Factors; Ultrasonography, Doppler	2015
Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Annals of the rheumatic diseases, 2015, Volume: 74, Issue:5 Topics: Adult; Aged; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Autoantibodies; Cohort Studies; Disease Progression; Female; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Proportional Hazards Models; Remission Induction; Sulfasalazine; Time-to-Treatment; Treatment Outcome	2015
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:6 Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis	2015
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. Clinical rheumatology, 2015, Volume: 34, Issue:6 Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha	2015
Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis. Internal medicine journal, 2015, Volume: 45, Issue:12 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Sulfasalazine; Treatment Outcome; United States	2015
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions. Journal of pharmaceutical and biomedical analysis, 2016, Jan-25, Volume: 118 Topics: Administration, Oral; Amlodipine; Chloroquine; Chromatography, High Pressure Liquid; Dapsone; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Isoxazoles; Phenytoin; Pyridoxine; Sulfadiazine; Sulfasalazine; Suspensions; Tetracycline; Trimethoprim; Zonisamide	2016
Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis. Clinical therapeutics, 2016, Volume: 38, Issue:3 Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Hispanic or Latino; Humans; Isoxazoles; Leflunomide; Male; Medicaid; Medication Adherence; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Texas; United States; Young Adult	2016
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ open, 2017, 01-05, Volume: 7, Issue:1 Topics: Abatacept; Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Case-Control Studies; Etanercept; Female; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Odds Ratio; Risk Factors; Rituximab; Severity of Illness Index; Sulfasalazine; Taiwan; Time Factors; Tumor Necrosis Factor-alpha; Young Adult	2017
Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis. The Journal of rheumatology, 2017, Volume: 44, Issue:12 Topics: Adult; Age Factors; Aged; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Argentina; Arthritis, Rheumatoid; Chile; Female; Genotype; Humans; Indians, North American; Indians, South American; Isoxazoles; Leflunomide; Male; Methotrexate; Mexico; Middle Aged; Peru; Radiography; Rheumatoid Factor; Sex Factors; Sulfasalazine	2017